Physician profile
Alena Reznik
NPI 1871720987
$101,383.31
in general payments reported to CMS, 2019-2025
24 companies · $1,351 in 2025
The $1,351 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $19K · 2021: $13K · 2022: $12K · 2023: $8,567 · 2024: $16K · 2025: $1,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $3,397 · Entertainment: $25.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,695.00 |
| Food and Beverage | $3,396.95 |
| Entertainment | $25.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $24,200.04 | 2019-2021 | |
| Glaukos Corporation | $23,385.42 | 2019-2025 | Idosetr, Istent Infinite, Idose |
| Abbvie INC. | $20,901.33 | 2022-2025 | |
| Allergan, INC. | $20,213.11 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $3,757.44 | 2019-2024 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Alcon Research LLC | $2,820.00 | 2023-2024 | Hydrus Microstent |
| Dompe Farmaceutici S.P.A. | $2,400.00 | 2024 | |
| Alcon Vision LLC | $1,401.72 | 2020-2025 | Argos, Rocklatan, Clareon |
| New World Medical,INC. | $536.28 | 2019-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Sight Sciences, INC. | $434.79 | 2021-2024 | Omni Surgical System |
| Amgen INC. | $297.13 | 2025 | Tepezza |
| Ivantis, INC | $181.30 | 2019 | |
| Oyster Point Pharma, INC. | $138.67 | 2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $119.87 | 2025 | Xdemvy |
| Thea Pharma INC. | $118.38 | 2025 | Iyuzeh |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $112.64 | 2023 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $111.63 | 2019 | |
| Nova Eye, INC. | $67.78 | 2025 | |
| Stryker Corporation | $51.52 | 2019 | |
| Bausch & Lomb Americas INC. | $48.42 | 2023 | Vyzulta, Miebo |
| Rxsight INC | $28.70 | 2022 | |
| Optos, INC. | $25.98 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $17.11 | 2020 | |
| Beaver-Visitec International, INC. | $14.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alena Reznik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.